Elsevier B.V. acquired 3D4Medical Limited from Malin Corporation plc (ISE:MLC) and others for €46million on November 27, 2019. The sale of 3D4Medical will generate net cash proceeds of over €17 million for Malin. 3D4Medical incurred a loss before tax of approximately €0.49 million ($0.56 million)for the year ended 31 December 2018. John Moore, Chief Executive Officer and Founder will stay with 3D4Medical while pursuing other business interests. The proceeds will allow the seller to cut down its debt with the European Investment Bank. Elsevier B.V. completed the acquisition of 3D4Medical Limited from Malin Corporation plc (ISE:MLC) and others on November 27, 2019.